Presentations at the Third European Stereotactic Radiation Therapy and Whole Body Radiotherapy Workshop Highlight Clinical Outcomes and Emerging Trends
Results Presented in Spine, Lung, Liver and Prostate Treatment Emphasized the Benefits of Whole Body Radiosurgery
SUNNYVALE, Calif., July 6 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY ), a global leader in the field of radiosurgery, today announced highlights from the Third European Stereotactic Radiation Therapy and Whole Body Radiotherapy Workshop, held in Brussels, Belgium on May 28 and May 29. Event attendees included 220 health professionals, ranging from radiation oncologists and neurosurgeons to medical physicists and hospital administrators from 27 countries.
Focusing on new developments in the field, the independent Scientific Committee developed a multi-disciplinary educational event as an overview of the current state-of-the-art in intracranial and extracranial radiosurgery and Stereotactic Body Radiation Therapy (SBRT). Data on clinical usage were presented in areas such as the management of CNS lesions as well as managing tumor movement in the spine, prostate, lung, and liver. The Scientific Committee was lead by Prof. Peter Levendag (Erasmus MC, Daniel den Hoed Cancer Center, Rotterdam, The Netherlands), and co-chaired by Prof. Vincent Gregoire (Universite Catholique de Louvain, Brussels, Belgium) and Prof. Eric Lartigau (Centre Oscar Lambret, Lille, France),
"The extreme precision of technologies such as the CyberKnife System, along with better definition o